Stay updated on PF-06439535 vs Bevacizumab in NSCLC Clinical Trial
Sign up to get notified when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.

Latest updates to the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedA 403 Forbidden error page now loads where the study record would be, replacing the usual content such as study details and contacts with an error screen. This indicates an access issue on the page, rendering the record temporarily unavailable to users.SummaryDifference17%

- Check19 days agoChange DetectedThe revision label on the page updated from v3.6.6 to v3.7.0, indicating a back-end or template upgrade rather than a change to the study details shown on the page.SummaryDifference0.0%

- Check33 days agoChange DetectedRevision metadata updated from v3.6.5 to v3.6.6, signaling a new release version. No user-facing content is affected by this change.SummaryDifference0.0%

- Check40 days agoChange DetectedAn NIH grant/contract line (2014 ( U.S. NIH Grant/Contract )) was added to the study's external identifiers. This addition provides an explicit funding reference associated with the trial.SummaryDifference0.0%

- Check54 days agoChange DetectedThe page now displays Revision: v3.6.5 instead of the previous v3.6.4, indicating a minor site-release update.SummaryDifference0.0%

- Check75 days agoChange DetectedRevision updated from v3.6.3 to v3.6.4, indicating a platform-level update to the ClinicalTrials.gov interface.SummaryDifference0.0%

Stay in the know with updates to PF-06439535 vs Bevacizumab in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PF-06439535 vs Bevacizumab in NSCLC Clinical Trial page.